{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T05:43:45Z","timestamp":1771307025761,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.humpath.2022.05.008","type":"journal-article","created":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T11:10:14Z","timestamp":1652440214000},"page":"31-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Chromosomal aberrations, visualized using UroVysion\u00ae fluorescence in-situ hybridization assay, can predict poor prognosis in formalin-fixed paraffin-embedded tissues of cholangiocarcinoma patients"],"prefix":"10.1016","volume":"126","author":[{"given":"Sudarat","family":"Ainthachot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prakasit","family":"Sa-ngiamwibool","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malinee","family":"Thanee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sasithorn","family":"Watcharadetwittaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaovalux","family":"Chamgramol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chawalit","family":"Pairojkul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raksawan","family":"Deenonpoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2022.05.008_bib1","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/jhbp.536","article-title":"Differential diagnosis of cholangiocarcinoma and IgG4-related sclerosing cholangitis by fluorescence in situ hybridization using transpapillary forceps biopsy specimens","volume":"25","author":"Kato","year":"2018","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.humpath.2022.05.008_bib2","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nrgastro.2011.131","article-title":"Clinical diagnosis and staging of cholangiocarcinoma","volume":"8","author":"Blechacz","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.humpath.2022.05.008_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0040201","article-title":"Liver fluke induces cholangiocarcinoma","volume":"4","author":"Sripa","year":"2007","journal-title":"PLoS Med"},{"key":"10.1016\/j.humpath.2022.05.008_bib4","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrgastro.2016.51","article-title":"Expert consensus document: cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)","volume":"13","author":"Banales","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.humpath.2022.05.008_bib5","doi-asserted-by":"crossref","first-page":"20","DOI":"10.20517\/2394-5079.2018.46","article-title":"Intrahepatic cholangiocarcinoma: review and update","volume":"4","author":"Cardinale","year":"2018","journal-title":"Hepatoma Research"},{"key":"10.1016\/j.humpath.2022.05.008_bib6","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.path.2018.02.005","volume":"11","author":"Krasinskas","year":"2018","journal-title":"Cholangiocarcinoma. Surg Pathol Clin"},{"key":"10.1016\/j.humpath.2022.05.008_bib7","first-page":"625","article-title":"Intrahepatic cholangiocarcinoma","volume":"48","author":"Sirichindakul","year":"2004","journal-title":"Chula Med J"},{"key":"10.1016\/j.humpath.2022.05.008_bib8","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.suronc.2016.12.009","article-title":"Intrahepatic cholangiocarcinoma: molecular markers for diagnosis and prognosis","volume":"26","author":"Rahnemai-Azar","year":"2017","journal-title":"Surg Oncol"},{"key":"10.1016\/j.humpath.2022.05.008_bib9","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/mc.22925","article-title":"Over-expression of TNNI3K is associated with early-stage carcinogenesis of cholangiocarcinoma","volume":"58","author":"Yeh","year":"2019","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.humpath.2022.05.008_bib10","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.yexmp.2015.08.003","article-title":"Genome wide DNA copy number analysis in cholangiocarcinoma using high resolution molecular inversion probe single nucleotide polymorphism assay","volume":"99","author":"Arnold","year":"2015","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.humpath.2022.05.008_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/ajg.2014.433","article-title":"Biliary multifocal chromosomal polysomy and cholangiocarcinoma in primary sclerosing cholangitis","volume":"110","author":"Eaton","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.humpath.2022.05.008_bib12","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.21037\/tau-20-1207","article-title":"UroVysion fluorescence in situ hybridization in urothelial carcinoma: a narrative review and future perspectives","volume":"10","author":"Nagai","year":"2021","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.humpath.2022.05.008_bib13","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1007\/s10620-018-5280-4","article-title":"An increased chromosome 7 copy number in endoscopic bile duct biopsy specimens is predictive of a poor prognosis in cholangiocarcinoma","volume":"63","author":"Kato","year":"2018","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.humpath.2022.05.008_bib14","series-title":"AJCC cancer staging manual","author":"Amin","year":"2017"},{"key":"10.1016\/j.humpath.2022.05.008_bib15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-60761-789-1_1","article-title":"Fluorescence in situ hybridization (FISH), basic principles and methodology","volume":"659","author":"Garimberti","year":"2010","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.humpath.2022.05.008_bib16","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1053\/j.gastro.2015.08.046","article-title":"An optimized set of fluorescence in situ hybridization probes for detection of pancreatobiliary tract cancer in cytology brush samples","volume":"149","author":"Barr Fritcher","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.humpath.2022.05.008_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064186","article-title":"EGFR, FLT1 and heparanase as markers identifying\u00a0patients at risk of short survival in cholangiocarcinoma","volume":"8","author":"Hoffmann","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.humpath.2022.05.008_bib18","doi-asserted-by":"crossref","first-page":"7119","DOI":"10.1038\/s41598-018-25669-1","article-title":"Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma","volume":"8","author":"Simbolo","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.humpath.2022.05.008_bib19","series-title":"Diagnosis and management of cholangiocarcinoma: a multidisciplinary approach","year":"2021"},{"key":"10.1016\/j.humpath.2022.05.008_bib20","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002491","article-title":"Loss of BAP1 expression occurs frequently in intrahepatic cholangiocarcinoma","volume":"95","author":"Andrici","year":"2016","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.humpath.2022.05.008_bib21","first-page":"420","article-title":"BAP1 mutation-associated cholangiocarcinoma: an aggressive disease","volume":"33","author":"Anand","year":"2015","journal-title":"J Clin Orthod"},{"key":"10.1016\/j.humpath.2022.05.008_bib22","doi-asserted-by":"crossref","DOI":"10.1590\/0100-6991e-20181826","article-title":"Expression of epidermal growth factor receptor (EGFR) in cholangiocarcinomas: predictive factors and survival","volume":"45","author":"Gomes","year":"2018","journal-title":"Rev Col Bras Cir"},{"key":"10.1016\/j.humpath.2022.05.008_bib23","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1186\/s12885-019-6320-y","article-title":"HER2 gene (ERBB2) amplification is a rare event in non-liver-fluke associated cholangiocarcinogenesis","volume":"19","author":"Albrecht","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.humpath.2022.05.008_bib24","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10555-016-9645-x","article-title":"HER2\/HER3 pathway in biliary tract malignancies; systematic review and meta-analysis: a potential therapeutic target?","volume":"36","author":"Galdy","year":"2017","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.humpath.2022.05.008_bib25","first-page":"e15203","article-title":"Prognosis of HER2 expression in cholangiocarcinoma when evaluated using gastric cancer methodology of immunohistochemistry","volume":"33","author":"Fernandes","year":"2015","journal-title":"J Clin Orthod"},{"key":"10.1016\/j.humpath.2022.05.008_bib26","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1038\/modpathol.3880231","article-title":"Expression of p53 and PCNA in cholangiocarcinoma and primary sclerosing cholangitis","volume":"13","author":"Batheja","year":"2000","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2022.05.008_bib27","doi-asserted-by":"crossref","first-page":"14192","DOI":"10.18632\/oncotarget.13929","article-title":"Serum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma: clinical and prognostic implications","volume":"8","author":"Berretta","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.humpath.2022.05.008_bib28","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1006\/jsre.1999.5615","article-title":"Chromosome 9p21 loss and p16 inactivation in primary sclerosing cholangitis-associated cholangiocarcinoma","volume":"84","author":"Ahrendt","year":"1999","journal-title":"J Surg Res"},{"key":"10.1016\/j.humpath.2022.05.008_bib29","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1053\/gast.2002.36021","article-title":"p16INK4a Promoter mutations are frequent in primary sclerosing cholangitis (PSC) and PSC-associated cholangiocarcinoma","volume":"123","author":"Taniai","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.humpath.2022.05.008_bib30","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/gut.47.5.721","article-title":"Frequency of p16INK4A alterations and k-ras mutations in intrahepatic cholangiocarcinoma of the liver","volume":"47","author":"Tannapfel","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.humpath.2022.05.008_bib31","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1097\/01.PAT.0000454133.12330.87","article-title":"Liver fluke and cholangiocarcinoma in Thailand","volume":"46","author":"Pairojkul","year":"2014","journal-title":"Pathology"},{"key":"10.1016\/j.humpath.2022.05.008_bib32","article-title":"Diagnostic accuracy and value of chromosomal microarray analysis for chromosomal abnormalities in prenatal detection: a prospective clinical study","volume":"100","author":"Huang","year":"2021","journal-title":"Medicine (Baltim)"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817722001228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817722001228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:39:53Z","timestamp":1758645593000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817722001228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":32,"alternative-id":["S0046817722001228"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2022.05.008","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chromosomal aberrations, visualized using UroVysion\u00ae fluorescence in-situ hybridization assay, can predict poor prognosis in formalin-fixed paraffin-embedded tissues of cholangiocarcinoma patients","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2022.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}